Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
<p>Use of adjuvant hormone therapy across 10 years in women diagnosed with breast cancer in Stockholm, Sweden, 2005–2020. The dashed vertical lines indicate six months after finishing 5 years of adjuvant hormone therapy—a period that was used to define therapy extension.</p>
保存先:
| 第一著者: | |
|---|---|
| その他の著者: | , , , |
| 出版事項: |
2025
|
| 主題: | |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
| 要約: | <p>Use of adjuvant hormone therapy across 10 years in women diagnosed with breast cancer in Stockholm, Sweden, 2005–2020. The dashed vertical lines indicate six months after finishing 5 years of adjuvant hormone therapy—a period that was used to define therapy extension.</p> |
|---|